Eldridge invests in businesses across the Insurance, Credit, Technology, Real Estate, Sports, Media, and Consumer landscapes, seeking to build enterprises led by proven management teams.
Michele brings board and executive experience from Deutsche Bank, Eldridge Industries, and Zinnia. She currently serves as a non-executive director at Deutsche Bank and an operating partner at Eldridge.
The financing round was led by Glenview Capital and co-led by Novo Holdings.
"Everybody knows that dialysis care must improve. For this to happen, providers and physicians need products that allow greater flexibility to bring dialysis directly to the patient, while simplifying complexity and reducing the overall cost of care. Our small, simple-to-use, and powerful dialysis system SC+ is positioned to help transform kidney care. The funding we are announcing today will allow us to accelerate our emergence as a significant force in this market."
JPMorgan Chase and Eldridge join the investor group to extend the company's latest funding round.
"I’m delighted to welcome JPMorgan Chase and Eldridge to our world-class group of investors as we continue to strengthen and expand our local and alternative payment capabilities,"
Eldridge led the Series B round alongside existing backers Index Ventures, Sussex Place Ventures, and Contour Ventures.
"The pressure on business leaders to deliver more change at a faster pace, and with more resiliency, is not new. However, the move to a distributed and remote workforce has made it ever more challenging. As a result, we are seeing digital transformation and the drive to move work from analogue to digital, rising rapidly on the C-level agenda,"
